| Strain Name |
C57BL/6-H2-Eatm1(HLA-DRA1*1.1-I-Ea)Bcgen H2-Eb1tm1(HLA-DRB1*7.1-I-Eb1)Bcgen H2-Atm1Bcgen H2-Eb2tm1Bcgen/Bcgen |
Common Name |
B-hHLA-DRB1*7.1 mice |
| Background | C57BL/6 | Catalog number | 112948 |
|
Related Genes |
HLA-DRA1; SS1, DRB1, HLA-DRB, HLA-DR1B |
||
|
NCBI Gene ID |
3122, 3123 |
||
- HLA-DRA is one of the HLA class II alpha chain paralogues. HLA-DRB1 belongs to the HLA class II beta chain paralogs. This class II molecule is a heterodimer consisting of an alpha (DRA) and a beta (DRB) chain, both anchored in the membrane. It plays a central role in the immune system by presenting peptides derived from extracellular proteins. Class II molecules are expressed in antigen presenting cells (APC: B lymphocytes, dendritic cells, macrophages). The alpha chain is approximately 33-35 kDa and its gene contains 5 exons. The beta chain is approximately 26-28 kDa and its gene contains 6 exons. DRA does not have polymorphisms in the peptide binding part and acts as the sole alpha chain for DRB1, DRB3, DRB4 and DRB5.
- The exon 2 of mouse I-Ea gene that encodes the extracellular domain of I-Ea was replaced by human HLA-DRA encoding the α1 domain in B-hHLA-DRB1*7.1 mice. The exon 2 of mouse I-Eb1 gene that encodes the extracellular domain of I-Eb1 was replaced by human HLA-DRB encoding the β1 domain in B-hHLA-DRB1*7.1 mice. The mouse I-Aa, I-Ab1 and I-Eb2 were knocked out in B-hHLA-DRB1*7.1 mice.
- Human HLA-DR was exclusively detectable in homozygous B-hHLA-DRB1*7.1 mice, but not in wild-type C57BL/6 mice.
- B-hHLA-DRB1*7.1 mice provide a powerful preclinical model for in vivo evaluation of vaccines.
- Application: For example, this product is used for pharmacodynamics and safety evaluation of vaccines for cancers.
Strain specific HLA-DR expression analysis in wild-type C57BL/6 mice and homozygous B-hHLA-DRB1*7.1 mice by flow cytometry. Spleen cells were collected from wild-type C57BL/6 mice (+/+) and homozygous humanized B-hHLA-DRB1*7.1 mice, respectively, and analyzed by flow cytometry with species-specific anti-mouse I-A/I-E antibody (Biolegend, 107607), and species-specific anti-human HLA-DR antibody (Biolegend, 307610). Human HLA-DR was exclusively detectable in homozygous B-hHLA-DRB1*7.1 mice, but not in wild-type C57BL/6 mice.
Strain specific HLA-DR expression analysis in wild-type C57BL/6 mice and homozygous B-hHLA-DRB1*7.1 mice by flow cytometry. Blood cells were collected from wild-type C57BL/6 mice (+/+) and homozygous humanized B-hHLA-DRB1*7.1 mice, respectively, and analyzed by flow cytometry with species-specific anti-mouse I-A/I-E antibody (Biolegend, 107607), and species-specific anti-human HLA-DR antibody (Biolegend, 307610). Human HLA-DR was exclusively detectable in homozygous B-hHLA-DRB1*7.1 mice, but not in wild-type C57BL/6 mice.
Frequency of leukocyte subpopulations in lymph node by flow cytometry. Lymph nodes were isolated from wild-type C57BL/6 mice and homozygous B-hHLA-DRB1*7.1 mice (Female,8-week-old, n=3). A. Flow cytometry analysis of the lymph nodes cells was performed to assess the frequency of leukocyte subpopulations. B. Frequency of T cell subpopulations. Frequencies of T cells, B cells, NK cells, DCs, monocytes, macrophages, neutrophils, CD4+ T cells, CD8+ T cells and Tregs in B-hHLA-DRB1*7.1 mice were similar to those in C57BL/6 mice, demonstrating that humanization of HLA-DRB1*7.1 does not change the frequency or distribution of these cell types in lymph nodes.
